[AsCNP_S19] シンポジウム19
Future Development of Biomarker in Mental disorders

2019年10月11日(金) 16:30 〜 18:10 第12会場 (503)

Organizer / Chair: Andi Jayalangkara TANRA (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia), Co-chair: Minoru TAKEBAYASHI (Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Japan), Discussant: ‌Kristian LIAURY (Department of Psychiatry, Hasanuddin University, Indonesia)

Currently, there is an increasing number of techniques developed for biomarker of mental disorders.
One of that is the sAA (Salivary Alpha Amylase) Enzyme, which is produced by parotic gland in oral cavity. This enzyme could predict the level of stress from patients such as Psychotic, Depression, Bipolar and Anxiety through SAM (Sympathetic Adreno Medullary) system. Measuring the level of this enzyme is easy, safe and non-invasive, nonetheless the result is still in controversy.
However, the trait marker represents the properties of biological processeson behavior which play antecedent and possiblythe pathophysiology role of mental disorder such as schizophrenia.
Therefore, serotonin transporter (SERT) system is still challenging to be explored as a biological marker of major depression, focused in animal model. Dysregulation of immune system is also closely involved in the pathogenesis of depression.
Finally, the glutamate decarboxylase like protein 1 (GADL1)variant could be used as a biomarker to predict therapeutic response to lithium maintenance treatment in bipolar l patients.
The 4 speakers will give contribution for elaborating future development of Biomarker for mental disorders and will enhance interesting discussion in our symposium.

+全てマイスケジュールに登録

16:30 〜 16:34

[AsCNP-S19-Introduction] Introduction

^○Andi Jayalangkara TANRA (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia)

16:34 〜 16:57

[AsCNP-S19-1] Prediction of Response to TMS based on Neural Networks in Verbal Auditory Hallucinations of Schizophrenia Disorders using qEEG Cordance

^○Khamelia Malik PASITTAI¹, Mohammad SADIKIN¹, Nurmiati AMIR², Raldi Artono KOESTOER³ (1. Biomedical Doctoral Programme, Faculty of Medicine, Universitas Indonesia, 2. Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, 3. Faculty of Engineering, Universitas Indonesia)

16:57 〜 17:20

[AsCNP-S19-2] Salient and silent markers in mood disorders and relevant treatments

^○Chau-Shoun LEE^{1, 2}, Jung Chen CHANG³ (1. Department of Psychiatry, Mackay Memorial Hospital, Taiwan, 2. Department of Medicine, Mackay Medical College, Taiwan, 3. School of Nursing, College of Medicine, National Taiwan University, Taiwan)

17:20 〜 17:43

[AsCNP-S19-3] Development of animal models and biomarker for depression focused on serotonergic systems

^○Akihiro MOURI¹, Kazuo KUNISAWA^{1, 2}, Hidetsugu FUJIGAKI³, Yasuko YAMAMOTO³, Kuniaki SAITO³, Toshitaka NABESHIMA² (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan, 2. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan)

17:43 〜 18:06

[AsCNP-S19-4] Salivary Alpha Amylase (SAA) Enzyme as A Biomarker of Mental Disorders

^○Andi Jayalangkara TANRA, Sonny Teddy LISAL, Andi Suheyra SYAUKI (Department of Psychiatry, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia)

18:06 〜 18:10

[AsCNP-S19-Conclusion] Conclusion

^○Minoru TAKEBAYASHI (Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Japan)